|
| 38064663 | Comparing malignant monocytosis across the updated WHO and ICC classifications of 2022. | Blood | 2024 |
| 36725896 | Risk prediction in MDS: independent validation of the IPSS-M-ready for routine? | Leukemia | 2023 |
| 37756525 | Germ line variant GFI1-36N affects DNA repair and sensitizes AML cells to DNA damage and repair therapy. | Blood | 2023 |
| 37998731 | Galectin-10 Expression in Placentas of Women with Gestational Diabetes. | Curr Issues Mol Biol | 2023 |
| 37505914 | Interplay of TP53 allelic state, blast count, and complex karyotype on survival of patients with AML and MDS. | Blood Adv | 2023 |
| 37874914 | The clinical and genomic landscape of patients with DDX41 variants identified during diagnostic sequencing. | Blood Adv | 2023 |
| 37573403 | Risk assessment according to IPSS-M is superior to AML ELN risk classification in MDS/AML overlap patients defined by ICC. | Leukemia | 2023 |
| 36813994 | MDS subclassification-do we still have to count blasts? | Leukemia | 2023 |
| 36463343 | Mutations in spliceosome genes in myelodysplastic neoplasms and their association to ring sideroblasts. | Leukemia | 2023 |
| 36735768 | Specific subtype distribution with impact on prognosis of TP53 single-hit and double-hit events in AML and MDS. | Blood Adv | 2023 |
| 34845315 | Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia. | Leukemia | 2022 |
| 35617825 | Pathophysiologic and clinical implications of molecular profiles resultant from deletion 5q. | EBioMedicine | 2022 |
| 35468527 | Overexpression of galectin-4 in placentas of women with gestational diabetes. | J Reprod Immunol | 2022 |
| 35761024 | Rare germline alterations of myeloperoxidase predispose to myeloid neoplasms. | Leukemia | 2022 |
| 35725772 | AML, NOS and AML-MRC as defined by multilineage dysplasia share a common mutation pattern which is distinct from AML-MRC as defined by MDS-related cytogenetics. | Leukemia | 2022 |
| 36271152 | SF3B1 mutations in AML are strongly associated with MECOM rearrangements and may be indicative of an MDS pre-phase. | Leukemia | 2022 |
| 36261576 | SF3B1 mutated MDS: Blast count, genetic co-abnormalities and their impact on classification and prognosis. | Leukemia | 2022 |
| 35210415 | Circulating microbial content in myeloid malignancy patients is associated with disease subtypes and patient outcomes. | Nat Commun | 2022 |
| 35145272 | Aberrant somatic hypermutation of CCND1 generates non-coding drivers of mantle cell lymphomagenesis. | Cancer Gene Ther | 2022 |
| 34376804 | Indeterminate and oncogenic potential: CHIP vs CHOP mutations in AML with NPM1 alteration. | Leukemia | 2022 |
| 32753690 | Complex landscape of alternative splicing in myeloid neoplasms. | Leukemia | 2021 |
| 33714977 | Correction: complex landscape of alternative splicing in myeloid neoplasms. | Leukemia | 2021 |
| 34439083 | Maturation State-Specific Alternative Splicing in <i>FLT3</i>-ITD and NPM1 Mutated AML. | Cancers (Basel) | 2021 |
| 34406850 | Personalized Prediction Model to Risk Stratify Patients With Myelodysplastic Syndromes. | J Clin Oncol | 2021 |
| 34448812 | Splicing factor gene mutations in acute myeloid leukemia offer additive value if incorporated in current risk classification. | Blood Adv | 2021 |
| 34272482 | Author Correction: SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia. | Leukemia | 2021 |
| 34002025 | SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia. | Leukemia | 2021 |
| 34282718 | The diverse landscape of fusion transcripts in 25 different hematological entities. | Leuk Lymphoma | 2021 |
| 32289580 | Sex-specific epigenetic gene activation profiles are differentially modulated in human placentas affected by intrauterine growth restriction. | J Reprod Immunol | 2020 |
| 31980417 | The combination of WGS and RNA-Seq is superior to conventional diagnostic tests in multiple myeloma: Ready for prime time? | Cancer Genet | 2020 |
| 33126577 | Sex Specific Expression of Interleukin 7, 8 and 15 in Placentas of Women with Gestational Diabetes. | Int J Mol Sci | 2020 |
| 32573691 | Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasms. | Blood | 2020 |
| 32244351 | Placental Galectin-2 Expression in Gestational Diabetes: A Systematic, Histological Analysis. | Int J Mol Sci | 2020 |
| 32517091 | Cell Type- and Sex-Specific Dysregulation of Thyroid Hormone Receptors in Placentas in Gestational Diabetes Mellitus. | Int J Mol Sci | 2020 |
| 30854740 | Liver rupture in a 28-year-old primigravida with superimposed pre-eclampsia and hemolysis, elevated liver enzyme levels, and low platelet count syndrome. | J Obstet Gynaecol Res | 2019 |
| 31273095 | "Somatic" and "pathogenic" - is the classification strategy applicable in times of large-scale sequencing? | Haematologica | 2019 |
| 31209279 | DNMT3A mutations are over-represented in young adults with NPM1 mutated AML and prompt a distinct co-mutational pattern. | Leukemia | 2019 |
| 31089804 | Glucocorticoid receptors α and β are modulated sex specifically in human placentas of intrauterine growth restriction (IUGR). | Arch Gynecol Obstet | 2019 |
| 29311541 | Yolk sac macrophage progenitors traffic to the embryo during defined stages of development. | Nat Commun | 2018 |
| 30194428 | Author Correction: Yolk sac macrophage progenitors traffic to the embryo during defined stages of development. | Nat Commun | 2018 |
| 30558244 | Histone H3 lysine 9 acetylation is downregulated in GDM Placentas and Calcitriol supplementation enhanced this effect. | Int J Mol Sci | 2018 |
| 29472377 | TAAR1 induces a disturbed GSK3β phosphorylation in recurrent miscarriages through the ODC. | Endocr Connect | 2018 |
| 29686031 | Dopamine synthesis and dopamine receptor expression are disturbed in recurrent miscarriages. | Endocr Connect | 2018 |
| 29113124 | Role of Placental VDR Expression and Function in Common Late Pregnancy Disorders. | Int J Mol Sci | 2017 |
| 26901464 | Comparative analyses on expression of galectins1-4, 7-10 and 12 in first trimester placenta, decidua and isolated trophoblast cells in vitro. | Histol Histopathol | 2016 |
| 26418280 | Gal-1 silenced trophoblast tumor cells (BeWo) show decreased syncytium formation and different miRNA production compared to non-target silenced BeWo cells. | Cell Adh Migr | 2016 |
| 28076928 | RXRα is upregulated in first trimester endometrial glands of spontaneous abortions unlike LXR and PPARγ. | Eur J Histochem | 2016 |
| 27272852 | Immunocytochemical Characterization of Disseminated Tumour Cells from Bone Marrow of Breast Cancer Patients. | Anticancer Res | 2016 |
| 27272851 | New Marker Genes for Real-Time PCR-based Detection of Circulating Tumour Cells from Blood of Breast Cancer Patients. | Anticancer Res | 2016 |
| 27272850 | Endometrial Adenocarcinoma: Analysis of Circulating Tumour Cells by RT-qPCR. | Anticancer Res | 2016 |